Home

Ra Capital Management reported a 10.6% stake in Werewolf Therapeutics HOWL · 5,138,703 sh · amendment

Trade details

Type
5% stake report
Report
13D · amendment
Stake
10.6%
Last report
12.6% · filed 26/05/14
Shares held
5,138,703 sh
Class
Common Stock, $0.0001 par value per share
Event date
26/06/11
Filed
26/06/15

10.6% stake · −2.0pp from the last report

Stake
10.6%
Last report
12.6%
Since last report
−2.0pp

Werewolf Therapeutics trades, last 26 weeks

What else happened in Werewolf Therapeutics around then

Filed or reported within 30 days of the trade day · 05/12~07/11

Ra Capital Management's other 5% stake reports

  • Ra Capital Management

    5% stakeCorbus Pharmaceuticals Holdings

    9.9% stake

    Filed 09/30

  • Ra Capital Management

    5% stakeBetterLife Pharma

    9% stake

    Filed 09/22

  • Ra Capital Management

    5% stakeSionna Therapeutics

    14.3% stake

    Filed 09/21

  • Ra Capital Management

    5% stakeTyra Biosciences

    19.9% stake

    Filed 09/17

  • Ra Capital Management

    5% stakeJatt III Acquisition

    5.1% stake

    Filed 09/03